论文部分内容阅读
目的:脑梗死在脑血管疾病中占>85%,致死率高,疗效差,治愈率低,可导致完全性偏瘫、失语、昏迷及死亡。本文主要评价其治疗预后。方法:对815例脑梗死患者进行抗凝的低分子肝素钠治疗,并对治疗期间的自觉症状、血液变化、疗效判定对比观察。结果:816例有不同程度的神经系统症状和失语偏瘫等,经给予低分子肝素钠后>15天自觉症状减轻,记忆力逐渐恢复,1个月后适度改善,血凝状态比治疗前好转。结论:低分子肝素钠治疗脑梗死,在改善自觉症状及血凝变化方面具有一定的疗效,在临床治疗中值得推广应用。
Objective: Cerebral infarction accounts for> 85% of cerebrovascular diseases, with high lethal rate, poor curative effect and low cure rate. It can lead to complete hemiplegia, aphasia, coma and death. This article mainly evaluates its treatment prognosis. Methods: A total of 815 cases of patients with cerebral infarction were treated with anticoagulant low molecular weight heparin sodium. Contrastive observation was made on the subjective symptoms, blood changes and therapeutic effects during the treatment. Results: There were 816 cases of neurological symptoms and aphasia with hemiplegia. After the low molecular weight heparin sodium was given> 15 days, the symptoms were relieved. The memory gradually recovered. After 1 month, it was moderately improved. The state of blood coagulation was better than that before treatment. Conclusion: Low molecular weight heparin treatment of cerebral infarction, in improving the symptoms and changes in blood coagulation has a certain effect, worthy of promotion and application in clinical treatment.